Txp Neph @WUNephrology Dir. Kidney Txp @stlouisva co-chair KDWG @clingenresource. AE @KidneyMed. Rsrch #complement #genetics #TMA #AMD #Preeclampsia RT#endorse
Missouri, USA
- Tweets 8,857
- Following 795
- Followers 3,513
- Likes 27,886
Anuja Java, MD (she/her) retweeted
Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM) this Friday for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd
2
5
209
Anuja Java, MD (she/her) retweeted
Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM ) TODAY for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd
1
2
5
273
Today, on #aHUSAwarenessDay, we recognize the patients and families living with a rare and often unpredictable disease, and the community working alongside them!!
Every story adds to what we know. Every question still unanswered gives us a reason to keep going.
2
12
465
Anuja Java, MD (she/her) retweeted
🔬 Diagnosing #aHUS remains a clinical challenge. Clinicians & researchers: Help others navigate complex aHUS diagnosis & care by sharing your work/insights with colleagues w/#aHUS24Sept. An expert review from @anuja_java on this complex #raredisease:
pmc.ncbi.nlm.nih.gov/article…
5
6
313
Anuja Java, MD (she/her) retweeted
👏Check out recent publications @WashUNephrology by @Myasirbaloch, @anuja_java, @HumphreysLab, Chenjian Gu, and Yili Fang (Maggie Chen Lab).
nephrology.wustl.edu/washu-n…
2
2
442
Anuja Java, MD (she/her) retweeted
ISN e-symposium today on genetic and clinical implications in aHUS management @anuja_java
@ISNkidneycare
@ISNeducation
#ThisIsISN
#ISNWebinar
1
5
11
1,913
Congrats @ShrutiGkidney & @rc_oncneph for an engaging symposium! There is still so much to understand about complement in cancer, which makes the road ahead all the more exciting. Thank you for having me! Fantastic talks by @aishaikh @HerrmannMd @PepaSolerR @onconeph
🧵 Cancer & Complementology with Anuja Java
A fascinating look at how complement can be both friend and foe in cancer, and why context matters so much.
@anuja_java @rc_oncneph @ShrutiGkidney @harvardmed @DanaFarber
4
27
1,269
27 posts for one #TMA case feels about right 🤩. Really enjoyed working through diagnostic twists, complement ques, & t/t decisions with the @ISNkidneycare education team. Grateful for the invitation & for such a thoughtful, engaged discussion. @Dilushiwijay @myadla
27/n #ECNeph @ISNkidneycare @anuja_java @Dilushiwijay @myadla
Hope you had great learning!
Do check XSpace recording and continue conversation on X reg TMA !👈
Most imp,share what you do in your centres 👍
Economics play a major role in management 💰
Thankyou for joining us 🙌
2
2
10
1,278
New in @BloodPortfolio 🩸
Our “How I Treat” on TMA with clinical triggers.
When pregnancy, severe HTN or kidney txp coexist with TMA, when is the trigger enough & when to suspect complement-mediated disease & how to treat? A practical framework.
doi.org/10.1182/blood.202603…
1
18
58
5,482
Stephanie, you have done an amazing job with continuing the vision of FSLE! I really enjoyed meeting everyone and I genuinely hope the participants found it helpful. Wishing them all the very best again!
1
5
228
Delighted to see the full ISN “Genetics in Kidney Disease” curriculum now live.
Co-chaired and designed with #BeckyMa, this program was created to help nephrologists bring kidney genetics into practice, supporting earlier diagnosis, more individualized care, and better patient outcomes.
Grateful to the outstanding faculty and panelists who made it possible and to @ISNkidneycare for entrusting us with the opportunity to develop this curriculum!!
Access the ISN Genetics Curriculum, supporting nephrologists in using genetic testing for earlier diagnosis, personalized treatment, and improved patient outcomes: academy.theisn.org/products/…
The program features 11 expert-led recorded lectures and global roundtable discussions with practical, real-world insights into genetic principles and clinical applications.
Topics include genetics for nephrologists, clinical utility of genetic testing, polycystic kidney disease, Alport syndrome, and complement-mediated kidney diseases.
4
10
42
3,038
Grateful for a rich and memorable stretch in Asia this spring, from #ISNWCN in Yokohama to scientific exchange sessions in Korea during the gorgeous cherry blossom season!!
It was a privilege to share insights on genetic complementopathies in kidney disease, aHUS with triggers, the importance of multidisciplinary teams in aHUS and engage in interactive case-based discussions.
The warmth of reconnecting with friends and colleagues made the experience most meaningful - always inspired and deeply appreciative of our community🙏
@ISNWCN @ISNkidneycare @CharuMalik_ISN @DrDKavanagh @kidneydoc101 @Shuchi_Anand @mala_sachdeva @AnandhUrmila @hswapnil @SWadhwaniMD @NephLori @myadla @drmanishasahay @SabineKaram6 @SayaliBThakare @janewitwong @vjha126
3
4
46
1,501
As much as I love the energy around IgAN, I’m rooting for C3G to take the @NephMadness 👑
C3G has only 2 targeted therapies, yet each one represents something huge: translating complement biology into meaningful treatment for a disease that desperately needed options.
Not the deepest bench, but maybe the most meaningful win!!!
@Nephro_Sparks @anna_burgner @KidneyWars @ssfarouk @d_r_waguespack
#NephMadness 2026: The Left and Right Kidneys
Check out the 3rd round results on the #AJKDBlog: bit.ly/NM26Finalists
@Nephro_Sparks @anna_burgner @kidneywars @jrkott27 @catochita @krithicism @d_r_waguespack
@ssfarouk
3
3
21
2,214
C3G has entered its championship era!!
It is no longer just “interesting biology” but one of the most exciting treatment stories in nephrology 🤩
Loved writing this commentary on why complement-targeted therapies could be a real game changer for patients.
@NephMadness #Nephtwitter
#NephMadness 2026 Commentary by @anuja_java :
C3G – Treatments Look Poised to Win it All, A Massive Victory for Patients
bit.ly/NM26Java
2
7
43
2,909